COVID-19 had a strong impact in the first quarter of the year due to stockpiling and demand for products to treat cold/flu and COVID-19 symptoms. Growth is also expected as the cold/flu season returns in October and consumers will be more concerned over health and wellness and in dealing with cold/flu symptoms due to worries over COVID-19. The pandemic increased supply as manufacturers ran at maximum capacity to meet demand and shifted capacity to ensure the supply of high demand products.
The Analgesics in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
The Analgesics in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
KEY DATA FINDINGS
2020 IMPACT
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
2020 IMPACT
- Demand for analgesics supported by stockpiling in response to COVID-19
- Consumers shift towards e-commerce in response to COVID-19
- Multinationals leverage extensive distribution and product ranges to lead sales
- Ageing population supporting demand for analgesics
- Strong growth potential within topical analgesics/anaesthetics
- Interest in cannabis-based analgesics continues to rise
- Table 1 Sales of Analgesics by Category: Value 2015-2020
- Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020
- Table 3 NBO Company Shares of Analgesics: % Value 2016-2020
- Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020
- Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
- COVID-19 impact on consumer health
- COVID-19 country impact
- Company response
- Retailing shift
- What next for consumer health?
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
- Table 8 Life Expectancy at Birth 2015-2020
- Table 9 Sales of Consumer Health by Category: Value 2015-2020
- Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
- Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
- Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
- Table 14 Distribution of Consumer Health by Format: % Value 2015-2020
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2020
- Table 16 Forecast Sales of Consumer Health by Category: Value 2020-2025
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
- Summary 1 Research Sources
Note: Product cover images may vary from those shown
